Next Article in Journal
A Stepwise Screening Protocol for Multiple Myeloma
Next Article in Special Issue
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions
Previous Article in Journal
Routine Use of a Pocket-Sized Handheld Echoscopic Device Plus a Biomarker by Emergency Medicine Residents with an Early Screening Algorithm for Suspected Type A Acute Aortic Syndrome
Previous Article in Special Issue
Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
 
 
Article
Peer-Review Record

Association of Types of Sleep Apnea and Nocturnal Hypoxemia with Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

J. Clin. Med. 2023, 12(4), 1347; https://doi.org/10.3390/jcm12041347
by Haobo Xu, Juan Wang *, Shubin Qiao, Jiansong Yuan, Fenghuan Hu, Weixian Yang, Chao Guo, Xiaoliang Luo, Xin Duan, Shengwen Liu, Rong Liu and Jingang Cui *
Reviewer 1:
Reviewer 2: Anonymous
J. Clin. Med. 2023, 12(4), 1347; https://doi.org/10.3390/jcm12041347
Submission received: 5 November 2022 / Revised: 13 January 2023 / Accepted: 20 January 2023 / Published: 8 February 2023

Round 1

Reviewer 1 Report

Congratulations to all the authors for their work on this article. I would have a few comments about the article. 1. Logistic regression was used to assess the association between sleep disorder and AF. Did you use it for determine the independent risk factor?

2. The results were expressed as mean ± standard deviation, or number (percentage). For mean and standard deviation we use numeric variable, and for percentages we use categorical variable. Please, correct the sentence. 

3. Also, I have a question? Why was the lot divided into tertiles and not quartiles? Why was this decision made?

4. Association of types of sleep apnea and nocturnal hypoxemia with AF in patients with HCM. What statistical test did you use here? Cox regresion or Odd ratio test or maybe Chi-square test? 

 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The Authors present a study of the association of types of sleep apnea and nocturnal hypoxemia with atrial fibrillation in patients with hypertrophic cardiomyopathy.
The manuscript cannot be accepted for publication unless some issues are solved. Please find my comments below.
Major comments
The association between sleep apnea and atrial fibrillation is already known. The Authors should point out, where is the novelty of the presented manuscript.
There is likely a significant selection bias. The Author should explain in detail how the 606 HCM patients were selected for the sleep study.
Why were the patients with septal reduction therapy (SRT) excluded? The Authors report only 19 excluded patients. How do You explain that only 3% of the cohort is treated with SRT? This should be discussed in detail. Compare with the proportion of obstructive patients the presented cohort.
Why were the patients with NYHA class IV excluded?
The Methods section is not sufficient. Is there any follow-up? Is this a cross-sectional study with baseline characteristics only?
It is not clear, why the authors present in the Conclusion that the sleep apnea as "independently associated" with atrial fibrillation. In my opinion, this would need properly conducted multivariable analysis, including variables such as e.g., age, NYHA class, LA diameter, obesity, arterial hypertension, etc. A statistical review is needed here.



Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

The Authors present a resubmission of a study of the association of types of sleep apnea and nocturnal hypoxemia with atrial fibrillation in patients with hypertrophic cardiomyopathy. Please find my comments below.
Major comments
The association between sleep apnea and atrial fibrillation is already  known. The Authors admitted,  that the results of our study were only supplements to previous works. Therefore, the novelty of the presented manuscript is limited. Consider the scientific priority of this article.
The multivariable analysis did not include LA diameter, as a major predictor of atrial fibrillation.
Table 4. does not include all covariates in the multivariable analysis mentioned in the Authors' rebuttal letter. Was it performed or not?
The study flowchart is not clear. There is enormous selection bias. Only inpatients were included. It also seems that only severely symptomatic patients subsequently recommended for septal reduction therapy were included. Or is it a wrong impression? Methods sections needs to be further updated accordingly.




Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop